Name | TPO agonist 1 |
---|---|
Synonyms |
1H-Pyrazole-4,5-dione, 1-(3,4-dimethylphenyl)-3-methyl-, 4-[2-[2-hydroxy-3'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-3-yl]hydrazone], (4E)-
(4E)-2-(3,4-Dimethylphenyl)-4-{[2-hydroxy-3'-(2H-tetrazol-5-yl)-3-biphenylyl]hydrazono}-5-methyl-2,4-dihydro-3H-pyrazol-3-one |
Description | TPO agonist 1 can increase production of platelets by stimulating the TPO receptor in people with chronic ITP. (Idiopathic Thrombocytopenic Purpura)target: TPO receptor agonist1、TPO receptor agonists can be also used in Bone marrow fibrosis2、TPOreceptor agonists can decrease bleeding events and reduced need for adjunctive or rescue treatments. |
---|---|
Related Catalog | |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 703.5±70.0 °C at 760 mmHg |
Molecular Formula | C25H22N8O2 |
Molecular Weight | 466.495 |
Flash Point | 379.3±35.7 °C |
Exact Mass | 466.186584 |
LogP | 3.28 |
Vapour Pressure | 0.0±2.3 mmHg at 25°C |
Index of Refraction | 1.735 |
Storage condition | 2-8℃ |